Archivio

PENTA guidelines for the use of antiretroviral therapy 2004

72-week follow-up of HAART started in infants aged less than 3 months: CD4, viral load and drug resistance outcomes in the PENTA 7 study

Maintaining the nelfinavir trough concentration above 0.8 mg/L improves virologic response in HIV-1-infected children

Effect of concurrent zidovudine use on the resistance pathway selected by abacavir-containing regimens